Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Allogeneic Stem Cell Transplantation Versus Conventional Therapy for Advanced Primary Cutaneous T‐cell Lymphoma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438603/2/images/tooltip-triangle.png. Accessed 04 May 2024.
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438603/2/images/tooltip-triangle.png. Accessed May 4, 2024.
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438603/2/images/tooltip-triangle.png
Allogeneic Stem Cell Transplantation Versus Conventional Therapy for Advanced Primary Cutaneous T‐cell Lymphoma [Internet]. In: Cochrane Abstracts. [cited 2024 May 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438603/2/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
ID - 438603
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438603/2/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -